Masco Corporation MAS
Verdict: Sell. Fair value $67.45 against a price of $63.79 on 6 Jan 2026, 6% above the price.
In plain words
The case for: Narrow competitive moat provides durability.
The case against: Intense competitive pressure could compress margins. Revenue has declined for two consecutive years, from $8.68B in 2022 to $7.83B in 2024. Sustained.... Net Income in 2021 was anomalously low at $0.41B compared to an average of $0.86B in 2022-2024.....
Main risks
- Negative Stockholder Equity: Liabilities exceed the book value of assets ($-0.28B), rendering Debt/Equity and ROE metrics meaningless and signaling significant balance sheet risk, likely due to aggressive share repurchases.
- Declining Revenue Trend: Revenue has fallen from its 2022 peak, with both the 1-year (-1.8%) and 3-year (-2.2% CAGR) growth rates being negative, indicating potential market share erosion or cyclical headwinds.
- High Leverage: The estimated Net Debt to EBITDA ratio is over 3.1x, which is elevated and increases financial risk, particularly for a company with a declining top line.
- Revenue has declined for two consecutive years, from $8.68B in 2022 to $7.83B in 2024. Sustained...
- Intense competitive environment
- Revenue has declined for two consecutive years, from $8.68B in 2022 to $7.83B in 2024. Sustained revenue decline can create pressure on management to use aggressive accounting to meet earnings expectations.